Skip to content

Core Scientific, Inc. CORZ Impairment of long-lived assets

Impairment of long-lived assets at other companies

Humana logo
HumanaHUM
$2M-77.8%
Cleveland-Cliffs logo
Cleveland-CliffsCLF
$9.75M-50.6%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$0
Lineage, Inc. logo
Lineage, Inc.LINE
$1M-95.9%
Devon Energy logo
Devon EnergyDVN
$0-100%
Core Scientific, Inc. logo
Core Scientific, Inc.CORZ
$266.49M

Other financials

Income statement

See full
Revenue$115.2M+44.9%
Gross profit$30.1M+267%
Operating income-$310.4M-560%
Net income-$347.2M-160%
EPS (diluted)-$1.06-185%

Balance sheet

See full
Cash & equivalents$1.1B+64.0%
Total debt$2.2B+82.8%
Total equity-$1.3B-323%
Total assets$3.1B+88.9%

Cash flow

See full
Operating cash flow$249.9M+655%
CapEx$389.2M+363%
Free cash flow-$139.3M-8.0%

Valuation

See full
Market cap$9.27B+121%
Enterprise value$10.28B+119%
P/S26.1×+15.9×

Profitability

See full
Gross margin16.9%+4.3pp
Operating margin-144.7%-478pp
Net margin-238.9%-1.8pp
FCF margin-130%-246pp

Returns & leverage

See full
Return on equity-242.4%
Debt / equity2.2×
Current ratio0.5×-3.7×

Where this comes from

Reported directly by Core Scientific, Inc. in its filing.

Tagged under the XBRL concept us-gaap:TangibleAssetImpairmentCharges.

The official record: Core Scientific, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Core Scientific, Inc.'s impairment of long-lived assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Core Scientific, Inc.'s impairment of long-lived assets?
Core Scientific, Inc. (CORZ) reported impairment of long-lived assets of $266.49M in Q1 2026.
What does impairment of long-lived assets mean?
A non-cash charge recognized when the carrying amount of a tangible asset exceeds its recoverable amount. It reflects a downward adjustment in the value of infrastructure or equipment due to market changes or technological obsolescence.